Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. The Institute for Clinical and… Read More »
Media outlets report on news from Virginia, Missouri, Wisconsin, Minnesota, Connecticut, Georgia, California, Oregon, Ohio, Florida and Maryland. The Washington Post: Democrats File First Bills For The New Virginia General Assembly, Staring With Equal Rights Amendment Democratic lawmakers rushed to file bills Monday as the legislative window opened for next year’s General Assembly session, setting… Read More »
Of the 16 million American adults who live with depression, as many as one-quarter gain little or no benefit from available treatments, whether drugs or talk therapy. They represent perhaps the greatest unmet need in psychiatry. On Tuesday, the Food and Drug Administration approved a prescription treatment intended to help them, a fast-acting drug derived… Read More »